Report cover image

Viral Vector and Plasmid DNA: Technologies and Global Markets

Publisher BCC Research
Published Mar 12, 2024
Length 128 Pages
SKU # WA18628188

Description

Viral Vector and Plasmid DNA: Technologies and Global Markets



Report Scope:

The report provides a comprehensive summary of the viral vector and plasmid DNA technologies market focusing cell and gene therapies, along with detailed competitive landscape and profiles of key market players that include revenue, product portfolios and recent activities. The report analyzes trends and dynamics, including drivers, limitations, challenges, and opportunities. This research study discusses historical, current, and potential market size. The report will enable market players and new entrants to make informed decisions about the production and licensing of goods and services. Organizations, distributors, and exporters should find the information about market development and trends useful. The study segments the market on the basis of product type, applications, and end use. Geographical market analysis is provided for all the major segments. The report offers country-level analysis of markets to provide a better understanding of the major segments.

The market is divided into segments and by application/industry as follows:

By product type:

Viral vector.

Plasmid DNA.

By application:

Cancer.

Genetic disorders.

Infectious diseases.

Cardiovascular diseases.

Other diseases.

By end-user:

Research institutes.

Pharmaceutical and biopharmaceutical companies.

Each area is covered in detail, identifying current products in the market in the base year (2022), measuring the current market size and identifying current and potential market drivers, forecasting for 2028, assessing current and potential competitors, and identifying current competitor market shares for 2022.

Report Includes:

93 data tables and 47 additional tables

An overview of the global market for viral vector and plasmid DNA

Analyses of global market trends, with data from 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028

Evaluation of the current market size and revenue growth prospects for viral vector and plasmid DNA, along with a market share analysis by product type, application and geographic region

A look at the innovations, technological advances, and product launches from leading companies

Analysis of the industry’s regulatory framework and policies, and its product pipeline

Discussion of ESG challenges and ESG practices

Analysis of the key companies’ market shares, proprietary technologies, strategic alliances and other market strategies, and patents

Profiles of the leading players in the industry

Table of Contents

128 Pages
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Viral Technology
Cell and Gene Therapy
Chapter 3 Market Dynamics
Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Chapter 4 Emerging Technologies and Developments
Overview
AI in Viral Vector Production
Doggy Bone DNA
FRAGment Recycler: A New Technology for Plasmid DNA Synthesis
Patents
Patent Holdings by Manufacturer
Clinical Trials
Selected Clinical Trials of Viral Vectors and Plasmid DNA Technologies
Chapter 5 Global Market for Viral Vector and Plasmid DNA Technologies
Segmentation Breakdown
Market Breakdown by Product Type
Market Breakdown by End User
Research Institutes
Pharmaceutical and Biopharmaceutical Companies
Market Breakdown by Application
Cancer
Genetic Disorders
Infectious Diseases
Cardiovascular Diseases
Other Diseases
Geographic Breakdown
Market Breakdown by Region
North America
Latin America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Intelligence
Industry Scenario
Company Shares
Competitive Landscape among Companies
Competitive Landscape in Viral Vectors
Competitive Landscape in Plasmid DNA
Chapter 7 Sustainability in the Market for Viral Vector and Plasmid DNA Technologies: An ESG Perspective
Introduction
Environmental Factors
Social Factors
Governance Factors
ESG Performance among Major Companies
ESG Performance of Select Companies
Lonza: ESG Performance
Thermo Fisher Scientific: ESG Performance
Conclusion
Chapter 8 Appendix
Research Methodology
Acronyms
References
Company Profiles
AGILENT TECHNOLOGIES INC.
BLUEBIRD BIO INC.
CATALENT INC.
DANAHER CORP.
FUJIFILM HOLDINGS CORP.
GENSCRIPT
GILEAD SCIENCES INC.
LONZA
NOVARTIS AG
OXFORD BIOMEDICA PLC
PLASMIDFACTORY GMBH
REGENXBIO INC.
THERMO FISHER SCIENTIFIC INC.
VGXI INC.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us